The nervous system relies on small signaling peptides to modulate how neurons communicate — influencing neurotrophic factor expression, neurotransmitter systems, and sleep-wake regulation. A subset of synthetic and endogenous peptides has become a focus of neuroscience research for the way they interact with these signaling pathways.
Three compounds are studied as representative regulatory neuropeptides — Semax, Selank, and DSIP — each acting on a distinct axis of central-nervous-system signaling: neurotrophic, neurotransmitter-modulatory, and sleep-regulatory.
Semax
What is Semax?
What it is: Semax is a synthetic heptapeptide and an analog of the ACTH(4-10) fragment of adrenocorticotropic hormone. Unlike ACTH, the Semax peptide carries no hormonal activity, which is why it is studied as a neuroactive rather than an endocrine molecule. Source
How It Works
What Researchers Study It For
Common Research Protocols
In published research, the Semax peptide is typically studied in rodent models via intranasal or systemic administration. A single application (50 µg/kg) has been reported to raise hippocampal BDNF protein approximately 1.4-fold and exon-III BDNF mRNA approximately 3-fold, alongside increased TrkB phosphorylation. Source
Community Interest Areas
Semax is widely discussed in the research community for its neurotrophic mechanism — it acts on the brain's own BDNF and NGF machinery rather than binding directly to a single neurotransmitter receptor. Investigators are particularly interested in how a short peptide can shift neurotrophin gene expression across multiple brain regions.
Selank
What is Selank?
What it is: Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) and an analog of the endogenous immunopeptide tuftsin. The Selank peptide is extended at the C-terminus to slow its breakdown and lengthen its duration of action. Source
How It Works
What Researchers Study It For
Common Research Protocols
The Selank peptide is typically studied in rodent gene-expression and neurotransmitter models. In one analysis of 84 neurotransmission-related genes, administration was reported to alter the expression of approximately 45 genes within one hour, with changes concentrated in the GABAergic system. Source
Community Interest Areas
Selank draws research interest for a GABAergic mechanism that has been compared, in published studies, to that of classical benzodiazepine compounds — but reported without the same sedative or dependence profile. This has positioned it as a subject of study for peptide-based routes to GABA-A modulation.
DSIP
What is DSIP?
What it is: DSIP (delta sleep-inducing peptide) is a naturally occurring nonapeptide (molecular weight 849) first isolated from cerebral venous blood. The DSIP peptide is named for its association with delta-wave activity during deep sleep. Source
How It Works
What Researchers Study It For
Common Research Protocols
DSIP has been studied across rabbit, rodent, and human sleep-EEG models since its isolation. Its notably short biological half-life makes pharmacokinetics and delivery a recurring focus of investigation, and its precise receptor has not been fully characterized. Source
Community Interest Areas
DSIP has been described in the literature as a long-standing research "riddle" — decades of study on an endogenous peptide whose exact receptor and mechanism remain uncharacterized. That open question keeps it a subject of basic-mechanism interest in sleep and circadian research.
How They Compare
Key Takeaways
- Semax acts on the brain's neurotrophin system (BDNF, NGF, and TrkB) rather than a single neurotransmitter receptor, and is studied for neuroprotection and cognition in animal models
- Selank modulates GABAergic and serotonergic signaling through a tuftsin-derived mechanism, and is studied for anxiolytic signaling without a classical sedative profile
- DSIP is studied for slow-wave sleep architecture and HPA-axis/circadian modulation, though its precise receptor remains uncharacterized
- Together these three peptides represent distinct axes of neuropeptide signaling — neurotrophic, neurotransmitter-modulatory, and sleep-regulatory
- The statements made on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). All products sold by 33 Degrees of Healing are provided strictly for research, laboratory, and investigational purposes only.
Related Research Compounds
Sources
- Dolotov OV, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006. PubMed
- Shadrina M, et al. The heptapeptide SEMAX stimulates BDNF expression in different areas of the rat brain in vivo. Ann N Y Acad Sci. 2003. PubMed
- Kolomin T, et al. Selank administration affects the expression of some genes involved in GABAergic neurotransmission. Front Pharmacol. 2016. PMC
- Narkevich VB, et al. Comparison of the effects of selank and tuftsin on the metabolism of serotonin in the brain of rats pretreated with PCPA. Eksp Klin Farmakol. 2009. PubMed
- Graf MV, Kastin AJ. Delta-sleep-inducing peptide (DSIP): a review. Neurosci Biobehav Rev. 1984. PubMed
- Kovalzon VM, Strekalova TV. Delta sleep-inducing peptide (DSIP): a still unresolved riddle. J Neurochem. 2006. PubMed
This article is for educational and research purposes only. It is not intended as medical advice. The compounds discussed are research chemicals not approved by the FDA for human use. Always consult qualified professionals and review current regulations before conducting any research.